Women’s Health in Primary Care: Navigating VTE risk with Hormonal Contraceptives & Understanding the Management of NVP

Dr Georgina Forbes

BMBS, DipGUM, DFSRH

Miss Jennifer Ramage

Wednesday 11 November 2026

Start Time: 19:30 | Finish Time: 21:30

2 hours CPD

PDF of speaker's slides for learning purposes

Appraisal certificate for your portfolio

Intended for UK HCPs only.

This promotional webinar has been organised and fully funded by Exeltis UK Ltd in conjunction with MediConf UK.

Exeltis products will be mentioned at this webinar.

Learning Objectives

Session 1 - Dr Georgina Forbes

Navigating the risks of VTE with hormonal Contraceptives

Session 2 - Miss Jennifer Ramage

NVP Management

EXE-E/INP-CORP-3611-v1 | October 2026

Agenda

19:30 - 20:30

Session 1 - Dr Georgina Forbes

Navigating the risks of VTE with hormonal Contraceptives

(inc. live Q&A session)

20:30 - 21:30

Session 2 - Miss Jennifer Ramage

NVP Management

(inc. live Q&A session)

21:30

Webinar Close

Meet the Speakers

Dr Georgina Forbes

BMBS, DipGUM, DFSRH

Specialist Doctor in Sexual and Reproductive Healthcare in Aneurin Bevan University Healthboard, South Wales.

Georgina Forbes is a Specialist Doctor in Sexual and Reproductive Healthcare who is passionate about providing treatment for women in their reproductive lives and beyond. She has worked in women's health since 2010 and currently works in Aneurin Bevan University Health Board providing high quality contraception and sexual healthcare. Her special interests include medically complex contraception and widening access to coils and implants. She greatly enjoys teaching other professionals about the importance of Women's healthcare and is an approved trainer with the FSRH.

Miss Jennifer Ramage

Book this event online

Wednesday 11 November 2026

Start Time: 19:30 | Finish Time: 21:30

By booking a place on this course, I understand and agree to all MediConf Terms and Conditions and in doing so, I am actively giving permission to receive materials, including via email related to this course which have been produced in conjunction with the pharmaceutical company that is sponsoring this MediConf webinar or on whose behalf we are organising the meeting.

This webinar will NOT be recorded for delegate later viewing due to the presentation being the Intellectual Property of the speaker.
The Zoom link to join the event will be emailed to the email address you booked with. This may be received into your spam/junk inboxes, please check.
If you cannot locate the Zoom link, please email webinar@mediconf.co.uk for assistance.

If you are planning to access the webinar by your mobile or tablet please make sure to download the Zoom app to participate in the Q&A.
We no longer offer the option to dial in using your phone due to the excessive fees charged.